Gyrus in the news

Guest User Guest User

Gyrus Capital Acquires a Majority Stake In ACBC

Gyrus Capital, a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors, is pleased to announce the acquisition of ACBC (Anything Can Be Changed), a Circular Science company and certified B Corp, recognised as the leading independent sustainability service provider and innovator, specialising in advanced R&D, product innovation, and sustainable, circular solutions for the fashion and lifestyle industries.

Read More
Guest User Guest User

LRE Medical Announces Appointment of New Chief Executive Officer

Munich, Germany – LRE Medical, a leading CDMO providing advanced diagnostic and life-science solutions, is pleased to announce the appointment of Dr. Klaus Lun as its new Chief Executive Officer, effective November 1, 2024. This strategic appointment is backed by Gyrus Capital, a prominent private equity firm specializing in transformational investments in healthcare and sustainability sectors.

Read More
Guest User Guest User

Gyrus Capital Agrees to Sell Intellera to Accenture (NYSE: ACN)

Accenture (NYSE: ACN) has agreed to acquire Intellera Consulting, an Italian consultancy firm operating in the public administration and healthcare sectors. The acquisition aligns with Accenture’s ongoing focus on helping Italian public service organizations enhance and transform their citizen services.

Read More
Paul Tidy Paul Tidy

Essential Pharma acquires Renaissance Pharma Ltd with its Clinical Stage Immunotherapy for the Treatment of High-Risk Neuroblastoma

Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd…

Read More
Guest User Guest User

Gyrus Capital holds final close on Gyrus Capital Fund II

Gyrus Capital S.A. (“Gyrus” or the “Firm”) an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced the final closing of Gyrus Capital Fund II (“Fund II”), raising €310 million and surpassing the €215 million raised for Gyrus Fund I (2021). Fund II consists of the Principal Fund and an open-ended Co-investment vehicle, allowing the Firm to make larger investments. With the close of Fund II, total funds raised since inception (November 2018) exceeds €750 million.

Read More
Guest User Guest User

dss+ Acquires ADS System Safety Consulting

The acquisition adds the specialized capabilities and deep expertise of the largest U.S. consultancy dedicated to public transport system safety, system security and fire and life safety.

Read More